R. Foà

In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.

F. Lauria, Donatella Raspadori, Damiano Rondelli et al. · PubMed · 1994 · 38 citations

Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.

R. Foà, Alessandro Guarini, Anna Gillio‐Tos et al. · PubMed · 1991 · 33 citations

Mixed-phenotype Acute Leukemia, Immunology, Blood Cell +18

Retroviral vector-mediated transfer of the tumor necrosis factor alpha gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect

Anna Gillio‐Tos, Alessandro Cignetti, G Rovera et al. · Blood · 1996 · 29 citations · Full text

Cytotoxic effectors activated by low‐dose IL‐2 plus IL‐12 lyse IL‐2‐resistant autologous acute myeloid leukaemia blasts

Antonella Vitale, Anna Guarini, Roberto Latagliata et al. · British Journal of Haematology · 1998 · 19 citations · Full text

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

R. Foà, Giovanni Battista Meloni, S. Tosti et al. · PubMed · 1990 · 16 citations

Hematological Malignancy, Residual Disease, Acute Leukemia Patients +7